Correlation Between Eupraxia Pharmaceuticals and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals and MAIA Biotechnology, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and MAIA Biotechnology.
Diversification Opportunities for Eupraxia Pharmaceuticals and MAIA Biotechnology
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eupraxia and MAIA is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Eupraxia Pharmaceuticals and MAIA Biotechnology
Assuming the 90 days horizon Eupraxia Pharmaceuticals is expected to under-perform the MAIA Biotechnology. But the pink sheet apears to be less risky and, when comparing its historical volatility, Eupraxia Pharmaceuticals is 1.31 times less risky than MAIA Biotechnology. The pink sheet trades about -0.03 of its potential returns per unit of risk. The MAIA Biotechnology is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 99.00 in MAIA Biotechnology on August 24, 2024 and sell it today you would earn a total of 116.00 from holding MAIA Biotechnology or generate 117.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 52.4% |
| Values | Daily Returns |
Eupraxia Pharmaceuticals vs. MAIA Biotechnology
Performance |
| Timeline |
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| MAIA Biotechnology |
Eupraxia Pharmaceuticals and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eupraxia Pharmaceuticals and MAIA Biotechnology
The main advantage of trading using opposite Eupraxia Pharmaceuticals and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Eliem Therapeutics |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |